DeutschNewstral
Article
jdsupra.com on 2015-01-23 19:21
Patent Trial and Appeal Board Rejects Petitions for Covered Business Method Patent Review of Orange Book-Listed Patents Claiming Methods of Controlling Access to Sensitive Drugs
Related news
- DOJ Files IPR Petitions Against Discovery Patentsjdsupra.com
- Post-Grant Review May Be Used to Invalidate Patents Directed to Patent-Ineligible Subject Matterjdsupra.com
- PTAB Denies Inter Partes Review Petitions Against Two Acorda Patentsjdsupra.com
- Mylan Files New IPR Petitions on Aflibercept Patentsjdsupra.com
- Celltrion and Samsung File IPR Petitions on Aflibercept Patentsjdsupra.com
- U.S. Patent Legislation: The STRONGER Patents Act of 2017jdsupra.com
- STRONG Patents Act of 2015 -- An Alternative Patent Reform Billjdsupra.com
Internet Patents closes $16.5M deal with Omaha patent companybizjournals.com- Proposed USPTO Fee Changes Will Make It Much More Expensive to Patent and to Challenge Patents on Therapeutics. You Have an Opportunity to Comment...jdsupra.com
PatentsArkansas Online- Key Members of Congress Urge USPTO to Curtail Discretionary Denials of IPR Petitions to Help Lower Drug Costs by Breaking Patent Thicketsjdsupra.com
- PATENTSArkansas Online
- All or Nothing: Supreme Court Prohibits PTAB From Partially Instituting AIA Petitions Challenging Patentsjdsupra.com
- Casting A New Light On Diagnostic Patents: “Methods Of Preparation” Patent-Eligiblejdsupra.com
- Pfizer files two IPR petitions on Genentech’s Patent Directed to Methods of Making Humanized Antibodiesjdsupra.com
The government and the courts are finally getting fed up with patent trolls — and stupid patentsLA Times